kolon TissueGene 950160 Algorithm Investment Report

1. Performance Analysis of Algorithm (Separate) 950160 Date
Period 3 months 100-m won
2015.12 2016.12 2017.12 Average 2018.03 2018.06 2018.09 2018.12 2019.03 2019.06
IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep)
Sales 3 133 32 56 11 9 9 11 11 11 10
O-profit -61 60 -407 -136 -36 -50 -33 -228 -679 -2,019 -87
N-income -63 73 -454 -148 -34 -48 -28 -230 -780 -2,648 -85
O-rate -2,033.3 45.1 -1,271.9 -1,086.7 -327.3 -555.6 -366.7 -2,072.7 -6,147.1 -18,230.5 -4,616.6
N-rate -2,100.0 54.9 -1,418.8 -1,154.6 -309.1 -533.3 -311.1 -2,090.9 -7,070.2 -23,907.2 -5,703.6
ROE -350.0 33.8 -28.4 -114.9 -7.0 -8.4 -7.1 -21.1 -54.8 -159.0 -42.9
Debt-ratio 488.9 95.4 20.2 201.5 16.6 15.7 14.1 19.9 21.5 23.2 18.5
Quick-ratio 1,700.0 780.6 1,461.2 1,314.0 1,438.7 1,315.7 1,698.0 1,201.4 1,123.1 1,072.0 1,308.1
reserve-ratio 1,700.0 21,600.0 0.0 11,650.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
EPS -103 120 -744 -243 -56 -79 -46 -377 -1,279 -4,340 -139
BPS 29 354 2,624 1,002 3,166 3,252 3,183 2,432 2,221 2,029 3,008
Dividends 0 0 0 0
2019-05-07
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ 144 %
High mid ~ 112 %
Mid ~ 81 %
Low mid ~ 50 %
Low price ~ 18 %
Indication price Range Current stock price Company score
24,092 W 24,092 W 20,536 W
20,536 W 20,536 W 16,980 W Evaluation
27,648 W 27,648 W~ 24,092 W
11,350 W
47.216,980 W 16,980 W 13,425 W
Low price
Normal
13,425 W 13,425 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Biotechnology 81 54 2,940 2,057
13,425원
16,980원
20,536원
24,092원
27,648원
Low price 11,350원
18.3%
49.6%
80.9%
112.3%
143.6%
0.%
20.%
40.%
60.%
80.%
100.%
120.%
140.%
160.%
0W
5,000W
10,000W
15,000W
20,000W
25,000W
30,000W
Low price Low mid Mid High mid High price
Indication price chart (Separate)
Indication price
kolon TissueGene
Gap
kolon TissueGene

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (Separate) 950160 Date
Period
Gap
(Indication /
stock)
Color
2019-05-07
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
11,350 W Low price 37.6 Normal 3,500,000 W
Suggested Purchase
Amount 1,176,258 W
Number of stocks
purchased 104
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 27,648 W 27,648 W~ ~ 24,092 W 144 % -1,688,998 W All selling
High mid 24,092 W 24,092 W ~ 20,536 W 112 % -1,320,498 W All selling
Mid 20,536 W 20,536 W ~ 16,980 W 81 % -951,997 W -46
Low mid 16,980 W 16,980 W ~ 13,425 W 50 % -583,497 W -34
low price 13,425 W 13,425 W ~ 0 W 18 % -214,997 W -16
2018.12.04 2019.01.04 2019.02.01 2019.03.07 2019.04.04 2019.05.03
22.5 51.8 48.8
Stock price rise
probability score
A Sector 47.0 45.8 46.6 46.4 51.8 47.9
37.6B Sector 20.8 43.8 46.4 46.4 51.7 49.6
Total average 33.9 44.8 36.2
57 % -6 %
2019.01.04 2019.02.01 2019.03.07 2019.04.04 2019.05.03
Total of
increase rate
Total score
A Sector -3 % 2 % -0 % 10 % -8 %
-2 % 50.3B Sector 52 % -69 % 44 % 10 % -4 %
Total average 24 % -24 % -61 %
-3% 2% -0%
10%
-8%
52%
-69%
44%
10%
-4%
24%
-24%
-61%
57%
-6%
-80%
-60%
-40%
-20%
0%
20%
40%
60%
80%
2019.01.04 2019.02.01 2019.03.07 2019.04.04 2019.05.03
Increase rate of stock price rise
A sector
B sector
Total average
kolon TissueGene
47 46 47 46
52
48
21
44
26
46
52 50
34
45
36
23
52
49
0
10
20
30
40
50
60
2018.12.04 2019.01.04 2019.02.01 2019.03.07 2019.04.04 2019.05.03
Stock price rise probability score
A sector
B sector
Total average

3. may
ded by
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
EDUCATION, M&A, IPO, RECOVER, CORPORATE RESTRUCTURING,
MANAGEMENT OF TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374